ГДЕ НУЖНА ЯДЕРНАЯ КАРДИОЛОГИЯ?

1. Wayne Forrest, Report: Nuclear medicine patient visits drop in 2006. 10/16/2007 http://www.auntminnie.com/index.asp? Sec=sup&Sub =mol&Pag=dis&ItemId=77910&wf=2126.

2. Kelion A D, S Richard Underwood. Myocardial perfusion scintigraphy in the UK: how much are we doing and how can we do more? //Heart 2005;91(Suppl IV): iv1.

3. Pennell DJ, et al. Nuclear cardiology in the UK: British Nuclear Cardiology Society Survey 1994// J Nucl Med Comm 1998;19:305– 313.

4. Shaw LJ, et al. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: part II.// J Nucl Cardiol 1997;4:52–60.

5. Hachamovitch R, et al, Stress Myocardial Perfusion Single-Photon Emission Computed Tomography Is Clinically Effective and Cost Effective in Risk Stratification of Patients With a High Likelihood of Coronary Artery Disease (CAD) But No Known CAD// JACC 2004;43:200–208.

6. Shaw LJ., et al. Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain// Eur Heart J, 2006 27, 2448–2458.

7. Shaw LJ, et al. Prognostic value and cost effectiveness of exerciseinduced ischemia by echocardiography versus SPECT imaging for the evaluation of patients with stable chest pain [abstract]// Circulation 2002;106(suppl II): II–610.

8. Lee DS, et al. Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of falsenegative results// J Nucl Cardiol. 2002 Sep-Oct;9(5):515-522.

9. Poornima IG, et al. Utility of myocardial perfusion imaging in patients with low-risk treadmill scores// JACC 2004;43:194-199.

10. Gibbons RJ, et al. Long-term outcome of patients with intermediaterisk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging// Circulation. 1999;100:2140-5.

11. Radensky PW, et al. Potential cost effectiveness of initial myocardial perfusion imaging for assessment of emergency department patients with chest pain // Am J Cardiol.1997 Mar 1;79(5):595-9.

12. Heller GV, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms// JACC, 1998; 31:1011-1017.

13. Udelson J E, et al. Radionuclide imaging in risk assessment after acute coronary syndromes //Heart 2004;90(Suppl V): v16–v25.

14. Mehta S, et al. Invasive versus conservative management of unstable angina and non–Q-wave infarction: a meta-analysis// Circulation. 1999;100 (Suppl I): I775.

15. Acampa W, et al. Prognostic Value of Myocardial Ischemia in Patients with Uncomplicated Acute Myocardial Infarction: Direct Comparison of Stress Echocardiography and Myocardial Perfusion Imaging// J.Nucl.Med., 2005 Vol. 46 No. 3 417-423.

16. G Mowatt, et al. Systematic review of the effectiveness and costeffectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction// Health Technology Assessment 2004; Vol. 8: No.30.

17. Rahman S L, et al. Nuclear cardiology in the UK: do we apply evidence based medicine? // Heart 2004;90(Suppl V): v37–v40.

18. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging–Executive Summary //Circulation. 2003;108:1404-1418.

19. Shaw LJ, Myocardial perfusion imaging in the evaluation of chest pain in the acute care setting: Clinical and economic outcomes// J Nucl Cardiol 2007;14: S133-138.

20. Wackers F J. Th., et al. Task Force 5: Training in Nuclear Cardiology// JACC. 2006;47; 898-904.

21. Gottschalk A. International Perspectives on Nuclear Cardiology// J.Nucl.Med.,, 2004, v. 45, № 3,19N-20N, 26N.